908 related articles for article (PubMed ID: 31292246)
21. Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.
Lin HM; Wang JC; Hu HS; Wu PS; Wang WH; Wu SY; Yang CC; Yeh TK; Hsu TA; Jiaang WT; Chao YS; Chern JH; Yueh A
Antimicrob Agents Chemother; 2013 Feb; 57(2):723-33. PubMed ID: 23165461
[TBL] [Abstract][Full Text] [Related]
22. PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases.
Delang L; Harak C; Benkheil M; Khan H; Leyssen P; Andrews M; Lohmann V; Neyts J
J Antimicrob Chemother; 2018 Dec; 73(12):3375-3384. PubMed ID: 30219827
[TBL] [Abstract][Full Text] [Related]
23. Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine Hepaciviruses.
Zhang Y; Kinast V; Sheldon J; Frericks N; Todt D; Zimmer M; Caliskan N; Brown RJP; Steinmann E; Pietschmann T
Microbiol Spectr; 2023 Aug; 11(4):e0128423. PubMed ID: 37341610
[TBL] [Abstract][Full Text] [Related]
24. Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.
Aloia AL; Eyre NS; Black S; Bent SJ; Gaeguta A; Guo Z; Narayana SK; Chase R; Locarnini S; Carr JM; Howe JA; Beard MR
Antivir Ther; 2015; 20(3):271-80. PubMed ID: 25222708
[TBL] [Abstract][Full Text] [Related]
25. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
26. Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.
Imhof I; Simmonds P
J Virol; 2010 May; 84(9):4597-610. PubMed ID: 20164226
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
[TBL] [Abstract][Full Text] [Related]
28. Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNA.
Upadhyay A; Dixit U; Manvar D; Chaturvedi N; Pandey VN
Mol Cell Proteomics; 2013 Jun; 12(6):1539-52. PubMed ID: 23429521
[TBL] [Abstract][Full Text] [Related]
29. Transient replication of a hepatitis C virus genotype 1b replicon chimera encoding NS5A-5B from genotype 3a.
Kylefjord H; Danielsson A; Sedig S; Belda O; Wiktelius D; Vrang L; Targett-Adams P
J Virol Methods; 2014 Jan; 195():156-63. PubMed ID: 24120570
[TBL] [Abstract][Full Text] [Related]
30. Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor.
Lin HM; Wang JC; Hu HS; Wu PS; Yang CC; Wu CP; Pu SY; Hsu TA; Jiaang WT; Chao YS; Chern JH; Yeh TK; Yueh A
Antimicrob Agents Chemother; 2012 Jan; 56(1):44-53. PubMed ID: 22006008
[TBL] [Abstract][Full Text] [Related]
31. A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.
Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Gursky VV; Samsonova MG; Samsonov AM; Clausznitzer D; Kaderali L; Kolchanov NA; Ivanisenko VA
PLoS One; 2014; 9(3):e91502. PubMed ID: 24643004
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
33. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
[TBL] [Abstract][Full Text] [Related]
34. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
Robinson M; Yang H; Sun SC; Peng B; Tian Y; Pagratis N; Greenstein AE; Delaney WE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.
Hartlage AS; Dravid P; Walker CM; Kapoor A
PLoS Pathog; 2021 Mar; 17(3):e1009391. PubMed ID: 33735321
[TBL] [Abstract][Full Text] [Related]
36. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
[TBL] [Abstract][Full Text] [Related]
37. Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance.
Liu C; Guo M; Han L; Lu J; Xiang X; Xie Q; Nouhin J; Duong V; Tong Y; Zhong J
J Med Virol; 2023 Sep; 95(9):e29103. PubMed ID: 37721366
[TBL] [Abstract][Full Text] [Related]
38. Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein.
Pouliot JJ; Thomson M; Xie M; Horton J; Johnson J; Krull D; Mathis A; Morikawa Y; Parks D; Peterson R; Shimada T; Thomas E; Vamathevan J; Van Horn S; Xiong Z; Hamatake R; Peat AJ
Antimicrob Agents Chemother; 2015 Oct; 59(10):6539-50. PubMed ID: 26259798
[TBL] [Abstract][Full Text] [Related]
39. Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells.
Yi M; Lemon SM
J Virol; 2004 Aug; 78(15):7904-15. PubMed ID: 15254163
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
